<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957291</url>
  </required_header>
  <id_info>
    <org_study_id>CHG vs PI in ophthalmology</org_study_id>
    <nct_id>NCT03957291</nct_id>
  </id_info>
  <brief_title>Chlorohexidine Versus Povidone Iodine as Apreoperative Ophthalmic Disinfectant</brief_title>
  <official_title>Chlorohexidine Versus Povidone Iodine as Apreoperative Ophthalmic Disinfectant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Is to assess the efficacy of preoperative disinfection with chlorohexidine and povidone
           iodine in different concentrations separately .

        2. Is to compare the efficacy of chlorohexidine to povidone iodine.

        3. Compare patient comfort after instillation of each disinfectant .

        4. To find which disinfectant is more effective tolerated and more safe for use .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: This is a single center prospective study comparing antiseptic efficacy and ocular
      surface irritation with PI (povidine iodine) and AC (aqueous chlorhexidine). . Prior to
      sugery patients who meet inclusion criteria will be identified and informed consent will be
      obtained. Study personnel will obtain two samples one from conjunctival sac and th other from
      skin around the eye. Topical antisepsis will then be applied, the first eye will be
      randomized to one drop of either PI 5% - 2.5% or AC 0.1%- 0.05% and the second eye will
      receive the other agent. One minute after instillation of the eye drop to each eye, patients
      will rate their pain in each eye using the Wong-Baker (smiley face) rating scale. After 15
      minutes the second swabs will be taken in the same manner as the first swabs. . On
      post-operative day three, study personnel will meet the patient and ask to rate the pain in
      each eye using the same verbal numerical rating scale and to perform slit lamb examination
      for any complication.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2019</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized prospective trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The participant will be masked to which drug they receive, the investigator performing the analysis will also be masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Comfort</measure>
    <time_frame>day three post operative</time_frame>
    <description>Patient Comfort using the Wong Baker FACES Pain Scale [Scale: 0(No pain) - 10 (Worst Pain)]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Culture of conjunctiva for bacteria</measure>
    <time_frame>7 days</time_frame>
    <description>Microbial flora in conjunctival swab</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Comfort</measure>
    <time_frame>I minute after disinfectant drop instilled</time_frame>
    <description>Patient Comfort using the Wong Baker FACES Pain Scale [Scale: 0(No pain) - 10 (Worst Pain)]</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Disinfectant Causing Toxic Effect</condition>
  <arm_group>
    <arm_group_label>Povidine-Iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving Povidine-Iodine in right eye, chlorhexidine in the left eye before operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chlorhexidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receiving Povidine-Iodine in left eye, chlorhexidine in the right eye before operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine</intervention_name>
    <description>chlorhexidine administration prior to ophthalmic surgery (compared to Povidine iodine )</description>
    <arm_group_label>chlorhexidine</arm_group_label>
    <other_name>aqueous Chlorhexidine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-Iodine</intervention_name>
    <description>Povidine iodine administration prior to ophthalmic surgery (compared to chlorhexidine)</description>
    <arm_group_label>Povidine-Iodine</arm_group_label>
    <other_name>betadine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current patient of the Assiute University Hospital arranged for ophthamic surgery

          -  Age greater than 12.

        Exclusion Criteria:

          -  Documented allergy to PI or AC

          -  Current diagnosis of infectious keratitis

          -  History of unilateral contact lens wear in the past 30 days

          -  Current unilateral use of prescription eye drops.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>asmaa mohamed, master</last_name>
    <phone>01094109699</phone>
    <phone_ext>01065637228</phone_ext>
    <email>am650124@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Prof. Mohamed Tarek Abdel-Monaem Abdel-Monaem, pHD</last_name>
    <phone>01007530025</phone>
    <email>mtarekelc@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018 Jan;29(1):19-32. doi: 10.1097/ICU.0000000000000437. Review.</citation>
    <PMID>28984794</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 18, 2019</study_first_submitted>
  <study_first_submitted_qc>May 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>May 20, 2019</last_update_submitted>
  <last_update_submitted_qc>May 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Asmaa mohammed mostafa</investigator_full_name>
    <investigator_title>Asmaa Mohamed Mostafa</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

